text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2024년 06월 30일\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n한미약품(주)\n상장\n2010.07.30\n경영참여\n42,207\n5,202,080\n41.4\n346,035\n\xa0 \xa0 \xa0\xa0104,041\r\n-\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0\xa05,306,121\r\n41.4\n\xa0346,035\r\n1,330,469\n109,168\n(주)제이브이엠\n상장\n2016.06.09\n경영참여\n129,150\n4,738,544\n39.2\n153,323\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0\xa04,738,544\r\n39.2\n\xa0153,323\r\n225,561\n23,876\n온라인팜(주)\n비상장\n2012.12.15\n경영참여\n3,000\n8,000,000\n100\n13,320\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0\xa08,000,000\r\n100\n\xa0 \xa013,320\r\n209,760\n16,761\n(주)에르무루스\n비상장\n1997.02.14\n경영참여\n500\n207,000\n98.6\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0\xa0207,000\r\n98.6\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\r\n1,715\n-116\n일본한미약품(주)\n비상장\n2007.06.08\n경영참여\n38\n500\n100\n8\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0500\r\n100\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa08\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\r\n-2\nHanmi Europe Limited\n비상장\n2008.09.18\n경영참여\n7\n3,000\n100\n7\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa03,000\r\n100\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa07\r\n5\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n한미(중국)유한공사\n비상장\n2016.05.31\n경영참여\n11,833\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\xa0\r\n100\n11,833\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n100\n\xa0 \xa011,833\r\n12,031\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n북경한미IT유한공사\n비상장\n2022.11.01\n경영참여\n4,350\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\xa0\r\n100\n4,350\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n100\n\xa0 \xa0 \xa04,350\r\n4,804\n497\n(주)에비드넷\n비상장\n2022.11.01\n경영참여\n3,856\n452,318\n50\n15,863\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0\xa093\r\n\xa0 \xa0\xa0452,318\r\n50\n\xa0 \xa015,956\r\n11,024\n1,695\n(주)테라시온바이오메디칼\n비상장\n2022.11.01\n단순투자\n1,539\n299,824\n24.67\n1,539\n\xa0 \xa01,199,296\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0\xa01,499,120\r\n24.67\n\xa0 \xa0 \xa01,539\r\n7,416\n-258\nAssertio Holdings, Inc.\n상장\n2023.07.31\n단순투자\n3,224\n442,609\n0.47\n611\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0\xa0151\r\n\xa0 \xa0\xa0442,609\r\n0.47\n\xa0 \xa0 \xa0 \xa0\xa0762\r\n369,309\n-428,006\nAlpha Tau Medical Ltd.\n상장\n2022.11.01\n단순투자\n5,961\n1,000,000\n1.44\n3,881\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n-366\r\n\xa0\xa01,000,000\r\n1.43\n\xa0 \xa0 \xa03,515\r\n138,466\n-37,595\n(주)연합뉴스티브이\n비상장\n2011.06.01\n단순투자\n500\n100,000\n0.83\n176\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0\xa0100,000\r\n0.83\n\xa0 \xa0 \xa0 \xa0\xa0176\r\n68,817\n2,291\n(주)토모큐브\n비상장\n2016.03.30\n단순투자\n1,000\n314,300\n6.02\n55\n\xa0 \xa0 \xa0\xa0314,300\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0\xa0628,600\r\n5.89\n\xa0 \xa0 \xa0 \xa0 \xa055\r\n19,763\n-23,550\n(주)바이오앱\n비상장\n2020.08.10\n단순투자\n4,500\n500,000\n4.94\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0\xa0500,000\r\n4.94\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\r\n15,319\n-6,358\nNoom, Inc.\n비상장\n2022.11.01\n단순투자\n210\n61,478\n0.12\n210\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\xa0\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0\xa054\r\n\xa0 \xa0 \xa0\xa061,478\r\n0.12\n\xa0 \xa0 \xa0 \xa0\xa0264\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\nAmplify Surgical, Inc.\n비상장\n2022.11.01\n단순투자\n2,266\n796,202\n6.22\n2,915\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\xa0\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0\xa0560\r\n\xa0 \xa0\xa0796,202\r\n6.22\n\xa0 \xa0 \xa03,475\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\nIntuitiveX, Inc.\n비상장\n2022.11.01\n단순투자\n283\n2,000,000\n15.14\n198\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\xa0\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0\xa015\r\n\xa0\xa02,000,000\r\n15.14\n\xa0 \xa0 \xa0 \xa0\xa0213\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\nAltPep Corporation\n비상장\n2022.11.01\n단순투자\n605\n377,557\n1.23\n605\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\xa0\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0\xa090\r\n\xa0 \xa0\xa0377,557\r\n1.23\n\xa0 \xa0 \xa0 \xa0\xa0695\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\nBloomlife, Inc.\n비상장\n2022.11.01\n단순투자\n1,425\n1,153,262\n5\n1,425\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\xa0\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0\xa0312\r\n\xa0\xa01,153,262\r\n5\n\xa0 \xa0 \xa01,737\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n㈜매쉬업벤처스\n비상장\n2022.11.01\n단순투자\n1,000\n1,000\n-\n1,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\xa0\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa01,000\r\n0\n\xa0 \xa0 \xa01,000\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\r\n(주)조인앤조인\n비상장\n2022.11.01\n단순투자\n502\n51,800\n2.64\n502\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0-\xa0\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0 \xa0\xa0-\r\n\xa0 \xa0 \xa0\xa051,800\r\n2.64\n\xa0 \xa0 \xa0 \xa0\xa0502\r\n9,540\n-201\n합 계\n-\n-\n557,856\n-\n-\n909\n-\n-\n558,765\n-\n-\n* 시장성 있는 지분증권의 공정가액은 보고기간 종료일 현재의 종가(당기말 현재의 종가가 없는 경우에는 직전 거래일의 종가)로 측정하였으며, 시장성없는 지분증권의 공정가액은 신뢰성있게 측정할 수 없어 피투자회사의 입수 가능한 최근 재무제표상의 순자산가액에 대한 당사 지분액으로 산정하였습니다.\n']"
